17-alpha-hydroxyprogesterone has been researched along with Myelolipoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jeon, JY; Lim, E | 1 |
| Honma, M; Imamura, M; Mori, M; Murakami, M; Nagai, T | 1 |
2 other study(ies) available for 17-alpha-hydroxyprogesterone and Myelolipoma
| Article | Year |
|---|---|
Congenital adrenal hyperplasia presenting as pelvic inflammatory disease in a phenotypic male: A case report.
Topics: 17-alpha-Hydroxyprogesterone; Administration, Intravenous; Adrenal Hyperplasia, Congenital; Anti-Bacterial Agents; Diagnosis, Differential; Female; Genitalia, Female; Humans; Male; Middle Aged; Myelolipoma; Pelvic Inflammatory Disease; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed; Treatment Outcome | 2020 |
17alpha-hydroxylase deficiency accompanied by adrenal myelolipoma.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Gland Neoplasms; Adrenal Hyperplasia, Congenital; Female; Hormones; Humans; Magnetic Resonance Imaging; Middle Aged; Myelolipoma; Treatment Outcome | 2001 |